Resistance to Ibritumomab in Lymphoma - Resistance to Targeted Anti-Cancer Therapeutics -  - Books - Springer Nature Switzerland AG - 9783030086527 - January 8, 2019
In case cover and title do not match, the title is correct

Resistance to Ibritumomab in Lymphoma - Resistance to Targeted Anti-Cancer Therapeutics Softcover Reprint of the Original 1st 2018 edition

Price
$ 106.99
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jul 1 - 7
Add to your iMusic wish list

This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.


158 pages, 11 Tables, color; 14 Illustrations, color; 4 Illustrations, black and white; XIII, 158 p.

Media Books     Paperback Book   (Book with soft cover and glued back)
Released January 8, 2019
ISBN13 9783030086527
Publishers Springer Nature Switzerland AG
Pages 158
Dimensions 150 × 220 × 10 mm   ·   254 g
Language German  
Editor Chatal, Jean-Francois
Editor Hosono, Makoto

Mere med samme udgiver